Abstract
Health writer Francesca Ramadan provides an overview of the implications of continuous glucose monitoring and ‘flash’ monitoring for patient care and costs, ahead of the upcoming National Institute for Health and Care Excellence guidelines.
Subject
Health Policy,Leadership and Management